tiprankstipranks
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market
Holding DNA?
Track your performance easily

Ginkgo Bioworks Holdings (DNA) Financial Statements

2,103 Followers

Ginkgo Bioworks Holdings Financial Overview

Ginkgo Bioworks Holdings's market cap is currently ―. The company's EPS TTM is $-12.903; its P/E ratio is -0.49; Ginkgo Bioworks Holdings is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 89.05M$ 56.21M$ 37.94M$ 34.76M$ 55.43M
Gross Profit$ 77.04M$ 42.48M$ 28.74M$ 23.60M$ 48.51M
EBIT$ -56.78M$ -216.99M$ -177.59M$ -167.88M$ -190.18M
EBITDA$ -32.06M$ -192.23M$ -159.09M$ -150.32M$ -169.69M
Net Income Common Stockholders$ -56.40M$ -227.49M$ -165.91M$ -211.69M$ -302.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 616.21M$ 730.37M$ 840.44M$ 944.07M$ 1.05B
Total Assets$ 1.48B$ 1.63B$ 1.58B$ 1.67B$ 2.03B
Total Debt$ 445.59M$ 452.26M$ 234.50M$ 221.84M$ 403.66M
Net Debt$ -170.62M$ -278.10M$ -605.94M$ -722.24M$ -645.58M
Total Liabilities$ 682.94M$ 792.18M$ 594.49M$ 568.19M$ 773.71M
Stockholders Equity$ 797.94M$ 833.07M$ 987.27M$ 1.10B$ 1.26B
Cash Flow-
Free Cash Flow$ -118.19M$ -111.23M$ -95.97M$ -61.28M$ -77.93M
Operating Cash Flow$ -103.50M$ -84.39M$ -89.26M$ -57.83M$ -73.55M
Investing Cash Flow$ -10.20M$ -26.84M$ -12.11M$ -46.67M$ -3.38M
Financing Cash Flow$ -465.00K$ -226.00K$ -845.00K$ -632.00K$ -315.00K
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Ginkgo Bioworks Holdings Debt to Assets

Ginkgo Bioworks Holdings Cash Flow

Ginkgo Bioworks Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis